Related Experiment Video
Updated: May 12, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Quantifying Personalized Shift-Work Molecular Portraits Underlying Alzheimer's Disease through Computational Biology
1Yanjie Jia, Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China. Email: Jiayanjie1971@zzu.edu.cn; Tao Peng, Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
Shift work causally increases Alzheimer's disease (AD) risk by disrupting circadian rhythms. This study identified key genes and developed a metric to assess circadian rhythm disruption (CRD) for disease prevention.
Area of Science:
- Neuroscience
- Genetics
- Chronobiology
Background:
- Shift work is a known circadian rhythm disruptor.
- Previous research suggests a link between shift work and increased Alzheimer's disease (AD) risk.
- The precise causal relationship and underlying mechanisms remain unclear.
Purpose of the Study:
- To investigate the causal effect of shift work on Alzheimer's disease (AD) risk.
- To identify specific circadian-related genes involved in shift work-induced AD.
- To develop a metric for quantifying circadian rhythm disruption (CRD) and its association with AD.
Main Methods:
- Mendelian randomization (MR) analysis to assess causality between shift work and AD.
- Integration of expression quantitative trait loci (eQTEs) and transcriptome data to identify candidate genes.
- In vitro validation of target gene expression.
- Development of a novel integrative program using 4,077 samples to calculate clock deviation level (CDL) for CRD assessment.
Main Results:
- Shift work was found to causally increase AD risk (OR = 2.49).
- Seven circadian-related genes (CCS, CDS2, MYRIP, NRP1, PLEKHA5, POLR1D, PPP4C) were identified as being causally associated with AD.
- Elevated CDL was observed in shift work, sleep restriction, and AD patient groups compared to controls.
- CDL showed significant correlation with AD clinical biomarkers.
Conclusions:
- This study provides evidence for the causal role of circadian rhythm disruption (CRD) in Alzheimer's disease (AD).
- Identified target genes offer potential therapeutic avenues for shift work-induced AD.
- The developed CDL metric can characterize CRD status, aiding in disease prevention and intervention strategies.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology

